DIVISLAB.NS WACC - Weighted Average Cost of Capital

The WACC of Divi's Laboratories Ltd (DIVISLAB.NS) is 13.2%.

The Cost of Equity of Divi's Laboratories Ltd (DIVISLAB.NS) is 13.20%.

The Cost of Debt of Divi's Laboratories Ltd (DIVISLAB.NS) is 19.15%.

	Range	Selected
Cost of equity	11.30% - 15.10%	13.20%
Tax rate	24.00% - 25.00%	24.50%
Cost of debt	7.50% - 30.80%	19.15%
WACC	11.3% - 15.1%	13.2%

WACC

DIVISLAB.NS WACC calculation

Category	Low	High

Long-term bond rate	6.9%	7.4%
Equity market risk premium	8.3%	9.3%
Adjusted beta	0.53	0.78

Additional risk adjustments	0.0%	0.5%
Cost of equity	11.30%	15.10%

Tax rate	24.00%	25.00%
Debt/Equity ratio	0	0
Cost of debt	7.50%	30.80%

After-tax WACC	11.3%	15.1%


Selected WACC	13.2%

DIVISLAB.NS's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for DIVISLAB.NS:

cost_of_equity (13.20%) = risk_free_rate (7.15%) + equity_risk_premium (8.80%) * adjusted_beta (0.53) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.